Novanta (NOVT) Current Deferred Revenue: 2010-2025
Historic Current Deferred Revenue for Novanta (NOVT) over the last 10 years, with Sep 2025 value amounting to $8.0 million.
- Novanta's Current Deferred Revenue fell 3.74% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year decrease of 3.74%. This contributed to the annual value of $5.7 million for FY2024, which is 2.92% up from last year.
- Novanta's Current Deferred Revenue amounted to $8.0 million in Q3 2025, which was up 16.28% from $6.9 million recorded in Q2 2025.
- In the past 5 years, Novanta's Current Deferred Revenue ranged from a high of $9.2 million in Q4 2021 and a low of $5.3 million during Q2 2021.
- Its 3-year average for Current Deferred Revenue is $6.9 million, with a median of $6.9 million in 2025.
- Its Current Deferred Revenue has fluctuated over the past 5 years, first surged by 102.42% in 2021, then slumped by 31.68% in 2023.
- Novanta's Current Deferred Revenue (Quarterly) stood at $7.0 million in 2021, then rose by 16.20% to $8.1 million in 2022, then plummeted by 31.68% to $5.6 million in 2023, then climbed by 2.92% to $5.7 million in 2024, then declined by 3.74% to $8.0 million in 2025.
- Its Current Deferred Revenue stands at $8.0 million for Q3 2025, versus $6.9 million for Q2 2025 and $8.2 million for Q1 2025.